Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Data443 Risk Mitigation (ATDS) Current Deferred Revenue (2018 - 2025)

Data443 Risk Mitigation filings provide 7 years of Current Deferred Revenue readings, the most recent being $1.4 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 40.89% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 40.89% decrease, with the full-year FY2025 number at $1.4 million, down 40.89% from a year prior.
  • Current Deferred Revenue reached $1.4 million in Q4 2025 per ATDS's latest filing, down from $2.1 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $2.5 million in Q4 2022, with the low at $1.1 million in Q2 2025.
  • A 4-year average of $1.8 million and a median of $1.8 million in 2023 define the central range for Current Deferred Revenue.
  • Year-over-year, Current Deferred Revenue skyrocketed 54.2% in 2023 and then crashed 40.89% in 2025.
  • Year by year, Current Deferred Revenue stood at $2.5 million in 2022, then dropped by 26.86% to $1.8 million in 2023, then grew by 26.43% to $2.3 million in 2024, then crashed by 40.89% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for ATDS's Current Deferred Revenue are $1.4 million (Q4 2025), $2.1 million (Q3 2025), and $1.1 million (Q2 2025).